HHS Secretary Alex Azar Statement on Illnesses Associated with E-Cigarettes

Washington, DC - As of August 27, 2019, health departments from 25 states have reported 215 possible cases of pulmonary illnesses from users of e-cigarette products, resulting in one death, and additional reports are under investigation. HHS Secretary Alex Azar issued the following statement:

FDA encourages inclusion of male patients in breast cancer clinical trials

Washington, DC - The draft guidance, Male Breast Cancer: Developing Drugs for Treatment, includes draft recommendations for inclusion of males in breast cancer clinical trials. Historically, males either have not been included in clinical trials for drugs to treat breast cancer or inclusion of males in those trials has been very limited; when finalized, the draft guidance will provide clarity for industry regarding clinical development of drugs to treat breast cancer in male patients.

Insomnia tied to higher risk of heart disease and stroke

Dallas, Texas - People suffering from insomnia may have an increased risk of coronary artery disease, heart failure and stroke, according to new research in the American Heart Association’s journal Circulation.

CDC, FDA, States Continue to Investigate Severe Pulmonary Disease Among People Who Use E-cigarettes

Washington, DC - 193 potential cases of severe lung illness associated with e-cigarette product use had been reported by 22 states (CA, CT, IL, IN, IA, MN, MI, NC, NJ, NM, NY, PA, TX, UT, WI, and additional states pending verification).  These were reported between June 28th and August 20th of this year.

Leaders of NIH’s All of Us Research Program recap progress and next steps

Washington, DC - The All of Us Research Program at the National Institutes of Health has made strong progress in its efforts to advance precision medicine, according to program leadership in a forthcoming paper in the New England Journal of Medicine.